EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 6, Pages e68226
Publisher
Public Library of Science (PLoS)
Online
2013-06-28
DOI
10.1371/journal.pone.0068226
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis
- (2012) Sandy Leung-Kuen Au et al. HEPATOLOGY
- Aberrations of EZH2 in Cancer
- (2011) A. Chase et al. CLINICAL CANCER RESEARCH
- 3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cells
- (2011) Tetsuhiro Chiba et al. INTERNATIONAL JOURNAL OF CANCER
- Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer
- (2011) H Taniguchi et al. ONCOGENE
- DLC1 Negatively Regulates Angiogenesis in a Paracrine Fashion
- (2010) Y.-P. Shih et al. CANCER RESEARCH
- An oncogene–tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB
- (2010) Junxia Min et al. NATURE MEDICINE
- The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer
- (2010) J Yu et al. ONCOGENE
- Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells
- (2009) W. Fiskus et al. BLOOD
- Rho-kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion
- (2009) Carmen Chak-Lui Wong et al. HEPATOLOGY
- DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation
- (2009) T. B. Miranda et al. MOLECULAR CANCER THERAPEUTICS
- Stem cell regulation by polycomb repressors: postponing commitment
- (2008) Alexandra M Pietersen et al. CURRENT OPINION IN CELL BIOLOGY
- Enhancer of Zeste Homologue 2 (EZH2) Down-regulates RUNX3 by Increasing Histone H3 Methylation
- (2008) Satoshi Fujii et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Roles of the EZH2 histone methyltransferase in cancer epigenetics
- (2008) Jeffrey A. Simon et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Repression of E-cadherin by the polycomb group protein EZH2 in cancer
- (2008) Q Cao et al. ONCOGENE
- Cancer Genes Hypermethylated in Human Embryonic Stem Cells
- (2008) Vincenzo Calvanese et al. PLoS One
- Deleted in Liver Cancer 1 (DLC1) Negatively Regulates Rho/ROCK/MLC Pathway in Hepatocellular Carcinoma
- (2008) Carmen Chak-Lui Wong et al. PLoS One
- DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms
- (2007) Kevin D. Healy et al. MOLECULAR CARCINOGENESIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started